Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate

Journal of Leukocyte Biology

Volumn 91, Issue 4, 2012, Pages 609-619

  Chakraborty, Paramita ^a   Chatterjee, Shilpak ^a   Ganguly, Avishek ^a   Saha, Piu ^b   Adhikary, Arghya ^c   Das, Tanya ^c   Chatterjee, Mitali ^b   Choudhuri, Soumitra Kumar ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c BOSE INSTITUTE   (India)

Author keywords

Intracellular GSH; Reactive oxygen species; Signaling

Indexed keywords

COPPER DERIVATIVE; COPPER N (2 HYDROXYACETOPHENONE)GLYCINATE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; IMMUNOSTIMULATION; MACROPHAGE; METASTASIS; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CHELATING AGENTS; ENZYME ACTIVATION; FEMALE; GLYCINE; INTERFERON-GAMMA; INTERLEUKIN-12; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 84860844691     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0611287     Document Type: Article

References (53)

1. Parkin, J., Cohen, B. (2001) An overview of the immune system. Lancet 357, 1777-1789.
2. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
3. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in micro environmental influences. J. Immunol. 175, 342-349.
4. Stout, R. D., Suttles, J. (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513.
5. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
6. Mantovani, A., Sica, A., Locati, M. (2005) Macrophage polarization comes of age. Immunity 23, 344-346.
7. Mosmann, T. R., Cherwinsk, I. H., Bond, M. W., Giedlin, M. A., Coffman, R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
8. Pollard, J. W. (2004) Tumor-educated macrophages promote tumor progression and metastasis. Nat. Rev. Cancer 4, 71-77.
9. Lin, E. Y., Pollard, J. W. (2004) Macrophages: modulators of breast cancer progression. Novartis Found. Symp. 256, 158-168.
10. Sunderkötter, C., Goebeler, M., Schulze-Osthoff, K., Bhardwaj, R., Sorg, C. (1991) Macrophage-derived angiogenesis factors. Pharmacol. Ther. 51, 195-216.
11. Bingle, L., Brown, N. J., Lewis, C. E., (2002) The role of tumour associated macrophages in tumour progression: implications for new antican-cer therapies. J. Pathol. 196, 254-265.
12. Bronte, V., Serafini, P., Apolloni, E., Zanovello, P. (2001) Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J. Immunother. 24, 431-446.
13. Leek, R. D., Harris, A. L. (2002) Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 7, 177-189.
14. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., Harris, A. L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56, 4625-4629.
15. Brigati, C., Noonan, D. M., Albini, A., Benelli, R. (2002) Tumors and inflammatory infiltrates: friends or foes? Clin. Exp. Metastasis 19, 247-258.
16. Bicknell, R., Harris, A. L. (1991) Novel growth regulatory factors and tumor angiogenesis. Eur. J. Cancer 27, 781-785.
17. Elgert, K. D., Alleva, D. G., Mullins, D. W. (1998) Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol. 64, 275-290.
18. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C, Manns, M. P., Greten, T. F., Korangy, F. (2008) A new population of my-eloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)FoxP3(+)T cells. Gastroenterology 135, 234-243.
19. Duluc, D., Corvaisier, M., Blanchard, S., Catala, L., Descamps, P., Game-lin, E., Ponsoda, S., Delneste, Y., Hebbar, M., Jeannin, P. (2009) Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 125, 367-373.
20. Watkins, S. K, Egilmez, N. K, Suttles, J., Stout, R. D. (2007) IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J. Immunol. 178, 1357-1362.
21. Chatterjee, S., Mookerjee, A, Mookerjee, J. B., Chakraborty, P., Ganguly, A, Adhikary, A, Mukhopadhyay, D., Ganguli, S., Banerjee, R., Ashraf, M., Biswas, J., Das, P. K, Sa, G., Chatterjee, M., Das, T., Choudhuri, S. K (2009) A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells. PLoS One 4, e7048.
22. Majumder, S., Panda, G. S., Choudhuri, S. K. (2003) Synthesis, characterization and biological properties of a novel copper complex. Eur. J. Med. Chem. 38, 893-898.
23. Mookerjee, A, Basu, J. M., Dutta, P., Majumder, S., Bhattacharyya, S., Biswas, J., Pal, S., Mukherjee, P., Raha, S., Baral, R N., Das, T., Efferth, T., Sa, G., Roy, S., Choudhuri, S. K. (2006) Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cyto-kine-mediated apoptosis. Clin. Cancer Res. 12, 4339-4349.
24. Lu, H. T., Yangm, D. D., Wysk, M., Gatti, E., Mellman, I., Davis, R J., Fla-vell, R A. (1999) Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBOJ. 18, 1845-1857.
25. Xiao, Y. Q., Freire-de-Lima, C. G., Schiemann, W. P., Bratton, D. L., Van-divier, R W., Henson, P. M. (2008) Transcriptional and translational regulation of TGF-β production in response to apoptotic cells. J. Immunol. 181, 3575-3585.
26. Otsuka, M., Goto, K, Tsuchiya, S., Aramaki, Y (2005) Phosphatidylserine-specific receptor contributes to TGF-β production in macrophages through a MAP kinase ERK. Biol. Pharm. Bull. 28, 1707-1710.
27. Murata, Y, Shimamura, T., Hamuro, J. (2002) The polarization of Th1/ Th2 balance is dependent on intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int. Immunol. 14, 201-212.
28. Kim, S. H., Johnson, V. J., Shin, T. Y, Sharma, R P. (2004) Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-appa]B signaling pathways. Exp. Biol. Med. 229, 203-213.
29. Carter, A. B., Knudtson, K. L., Monick, M. M., Hunninghake, G. W. (1999) The p38 mitogen-activated protein kinase is required for NF-kB- dependent gene expression. The role of TATA-binding protein (TBP). J. Biol. Chem. 274, 30858-30863.
30. Chandel, N. S., Trzyna, W. C, McClintock, D. S., Schumacker, P. T. (2000) Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J. Immunol. 165, 1013-1021.
31. Choudhuri, S. K., Chatterjee, A. (1998) Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis (N-phenyl) hy-droxamic acid in vitro. Anti-Cancer Drugs 9, 825-832.
32. Friche, E., Danks, M. K, Beck, W. T. (1992) Characterization of tumor cell resistance to 4-deoxy-4-iododoxorubicin developed in Ehrlich ascites cells in vitro. Cancer Res. 52, 5701-5706.
33. Majumder, S., Dutta, P., Mookerjee, A, Choudhuri, S. K. (2006) The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo. Chem. Biol. Inter. 159, 90-103.
34. Solinas, G., Schiarea, S., Liguori, M., Fabbri, M., Pesce, S., Zammataro, L., Pasqualini, F., Nebuloni, M., Chiabrando, C, Mantovani, A, Allavena, P. (2010) Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 185, 642-652.
35. Ganguly, A, Basu, S., Banerjee, K., Chakraborty, P., Sarkar, A, Chatterjee, M., Chaudhuri, S. K. (2011) Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis. Mol. Biosyst. 7, 1701-1712.
36. Debbas, V., Arai, R J., Ferderbar, S., Schindler, F., Stern, A, Monteiro, H. P. (2007) Regulation of p21Waf1 expression and TNFa biosynthesis by glutathione modulators in PMA induced-THP1 differentiation: involvement of JNK and ERK pathways. Biochem. Biophys. Res. Commun. 363, 965-970.
37. Utsugi, M., Dobashi, K, Koga, Y, Shimizu, Y, Ishizuka, T., Iizuka, K, Hamuro, J., Nakazawa, T., Mori, M. (2002) Glutathione redox regulates lipopolysaccharide-induced IL-12 production through p38 mitogen-activated protein kinase activation in human monocytes: role of glutathione redox in IFN-γ priming of IL-12 production. J. Leukoc. Biol. 71, 339-347.
38. Bradford, M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
39. Ganguly, A, Basu, S., Chakraborty, P., Chatterjee, S., Sarkar, A, Chatterjee, M., Choudhuri, S. K. (2010) Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate. PLoS One 5, e11253.
40. Mantovani, A, Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
41. Snijders, A, Hilkens, C. M. U. T., Pouw van der Kraan, Engel, M. M., Aarden L. A, Kapsenberg M. L. (1996) Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156, 1207-1212.
42. Hayes, M. P., Wang, J., Norcross, M. A. (1995) Regulation of interleu-kin-12 expression in human monocytes: selective priming by interferon-7 of lipopolysaccharide-inducible p35 and p40 genes. Blood 86, 646-650.
43. Flesch, I. E., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., Kaufmann, S. H. (1995) Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon 7 and tumor necrosis factor a. J. Exp. Med. 181, 1615-1621.
44. Wen, F. Q., Liu, X., Kobayashi, T., Abe, S., Fang, Q., Kohyama, T., Ertl, R, Terasaki, Y, Manouilova, L., Rennard, S. I. (2004) Interferon-7 inhibits transforming growth factor-/3 production in human airway epithelial cells by targeting SMADS. Am. J. Respir. Cell Mol. Biol. 30, 816-822.
45. Mathur, R K, Awasthi, A, Wadhone, P., Ramanamurthy, B., Saha, B. (2004) Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat. Med. 10, 540-544.
46. Feng, G. J., Goodridge, H. S., Harnett, M. M., Wei, X. Q., Nikolaev, A. V., Higson, A. P., Liew, F. Y (1999) Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163, 6403-6412.
47. Baeuerle, P. A, Henkel, T. (1994) Function and activation of NFk B in the immune system. Annu. Rev. Immunol. 12, 141-179.
48. Nakamura, H., Nakamura, K, Yodoi, J. (1997) Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369.
49. Ma, X., Chow, J. M., Gri, G., Carra, G., Gerosa, F., Wolf, S. F., Dzialo, R, Trinchieri, G. (1996) The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183, 147-157.
50. Ma, X., Neurath, M., Gri, G., Trinchieri, G. (1997) Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J. Biol. Chem. 272, 10389-10395.
51. Meister, A. (1989) Glutathione Centennial: Molecular Properties and Clinical Applications. Academic, New York, NY, USA.
52. Li, H., Wojciechowski, W., Dell'Agnola, C, Lopez, N. E., Espinoza-Del-gado, I. (2006) IFN-γ and T-bet expression in human dendritic cells from normal donors and cancer patients is controlled through mechanisms involving ERK-1/2-dependent and IL-12-independent pathways. J. Immunol. 177, 3554-3563.
53. Ghosh, R D., Das, S., Ganguly, A, Banerjee, K., Chakraborty, P., Sarkar, A, Chatterjee, M., Nanda, A., Pradhan, K, Choudhuri, S. K. (2011) An in vitro and in vivo study of a novel zinc complex, zinc N -(2-hydroxyace-tophenone)glycinate to overcome multidrug resistance in cancer. Dalton Trans. 40, 10873-10884.